Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ

INTRODUCTION: Interferon-β (IFNß) is the first-line treatment for relapsing-remitting multiple sclerosis. Myxovirus resistance protein A (MxA) is a marker of IFNß bioactivity, which may be reduced by neutralizing antibodies (NAbs) against IFNß. The aim of the study was to analyze the kinetics of MxA...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Libertinova, Jana, Meluzinova, Eva, Tomek, Ales, Horakova, Dana, Kovarova, Ivana, Matoska, Vaclav, Kumstyrova, Simona, Zajac, Miroslav, Hyncicova, Eva, Liskova, Petra, Houzvickova, Eva, Martinkovic, Lukas, Bojar, Martin, Havrdova, Eva, Marusic, Petr
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5231341/
https://ncbi.nlm.nih.gov/pubmed/28081207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0169957
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares